General form of registration statement for all companies including face-amount certificate companies

COMMITMENTS AND CONTINGENCIES (Details)

v3.19.2
COMMITMENTS AND CONTINGENCIES (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 01, 2019
USD ($)
shares
Jul. 31, 2018
USD ($)
shares
Jul. 01, 2018
USD ($)
shares
Apr. 06, 2018
USD ($)
Jan. 05, 2018
USD ($)
Nov. 30, 2017
USD ($)
shares
Oct. 09, 2017
USD ($)
Aug. 23, 2017
USD ($)
Jul. 20, 2016
USD ($)
Mar. 31, 2016
USD ($)
Aug. 01, 2015
USD ($)
shares
Oct. 01, 2014
USD ($)
Aug. 31, 2018
shares
Feb. 28, 2019
USD ($)
Feb. 28, 2018
USD ($)
May 31, 2018
USD ($)
May 31, 2017
USD ($)
Apr. 17, 2017
ft²
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Loss Contingency Accrual, Provision                           $ 10,000   $ 10,000    
Debt Conversion, Original Debt, Amount                           75,000 $ 112,500 150,000 $ 362,500  
Employee-related Liabilities, Current                           281,584   44,465 34,987  
Share-based Payment Arrangement, Expense                           17,500   794,607 3,250  
Chief Executive Officer [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Employment Agreement, Term                       5 years            
Salary and Wage, Officer, Excluding Cost of Good and Service Sold     $ 150,000                 $ 150,000            
Deferred Compensation Arrangement with Individual, Description     performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of the annual EBITDA                 performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million            
Share-based Compensation Arrangement by Share-based Payment Award, Description                       annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million            
Employee-related Liabilities, Current                           0   37,500 37,500  
Accrued Salaries                           31,806   0    
Chief Operating Officer [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Employment Agreement, Term                     5 years              
Salary and Wage, Officer, Excluding Cost of Good and Service Sold   $ 150,000                 $ 150,000              
Deferred Compensation Arrangement with Individual, Description   performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’ common stock in an amount equal to 3% of the annual EBITDA                 performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million              
Share-based Compensation Arrangement by Share-based Payment Award, Description                     annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million              
Employee-related Liabilities, Current           $ 37,500               37,500   37,500 0  
President and Chief Financial Officer [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Salary and Wage, Officer, Excluding Cost of Good and Service Sold $ 175,000         $ 175,000                        
Deferred Compensation Arrangement with Individual, Description performance bonus equal to 1% of our annual EBITDA         performance bonus equal to 2% of the Company’s annual EBITDA, and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA                        
Share-based Compensation Arrangement by Share-based Payment Award, Description           annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA                        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares 500,000                                  
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares                         600,000          
Former Officer [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Employee-related Liabilities, Current                           16,250   16,250 $ 16,250  
Building [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Area of Real Estate Property (in Square Feet) | ft²                                   14,392
Lessee, Operating Lease, Term of Contract                                   72 months
Lessee, Operating Lease, Renewal Term                                   10 years
Unpaid Accrued Salary Converted to Convertible Note [Member] | Convertible Debt [Member] | Chief Executive Officer [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Debt Conversion, Original Debt, Amount       $ 37,500 $ 37,500   $ 39,521 $ 62,500 $ 250,000 $ 112,500                
Deposit [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Loss Contingency Accrual, Provision                           50,000   50,000    
Rent Expense [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Loss Contingency Accrual, Provision                           15,699   15,699    
Remaining Amounts Due Under Lease [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Loss Contingency Accrual, Provision                           30,000   30,000    
One Time Signing Bonus [Member] | Chief Executive Officer [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares   500,000 500,000                              
Share-based Payment Arrangement, Expense                           236,667   $ 236,667    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   1 year 1 year                              
One Time Signing Bonus [Member] | Chief Operating Officer [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares   50,000                 250,000              
Share-based Payment Arrangement, Expense   $ 23,667                 $ 327,500     $ 23,667        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   1 year                 1 year              
One Time Signing Bonus [Member] | President and Chief Financial Officer [Member]                                    
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares           500,000                        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period           1 year